Environmental Toxic Neuropathies

  • Michael T. Pulley
  • Alan R. Berger


Toxic neuropathies include unintended or deliberate exposure to chemicals or heavy metals. These toxins often affect the peripheral nerves as well as the central nervous system, skin, hair, and gastrointestinal tract. This chapter discusses the diagnosis of peripheral neuropathies caused by toxins as well as the treatment and prognosis.


Toxic neuropathies poisoning lead arsenic thallium mercury carbon disulfide acrylamide organophosphates hexacarbons 


  1. 1.
    Kurland LT, Faro SN, Siedler H. Minamata disease. The outbreak of a neurologic disorder in minamata, Japan and its relationship to the ingestion of seafood contaminated by mercuric compounds. World Neurol. 1967;1:370–91.Google Scholar
  2. 2.
    Schaumburg HH, Spencer PS. Recognizing neurotoxic disease. Neurology. 1987;37:276–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Feldman RG. Lead. In: Occupational and environmental toxicology. Philadelphia: Lippincott-Raven Publishers; 1999. p. 30–68.Google Scholar
  4. 4.
    Goldman RH, Baker EL, Hannan M, Kamerow DB. Lead poisoning in automobile radiator mechanics. N Engl J Med. 1987;317:214–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Whitfield CL, Ch’ien LT, Whitehead JD. Lead encephalopathy in adults. Am J Med. 1972;52:289–98.PubMedCrossRefGoogle Scholar
  6. 6.
    Landrigan PJ, McKinney AS, Hopkins LC, Rhodes Jr WW, Price WA, Cox DH. Chronic lead absorption. Result of poor ventilation in an indoor pistol range. JAMA. 1975;234:394–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Markovac J, Goldstein GW. Lead activates protein kinase C in immature rat brain microvessels. Toxicol Appl Pharmacol. 1988;96:14–23.PubMedCrossRefGoogle Scholar
  8. 8.
    Silbergeld EK, Fales JT, Goldberg AM. Lead: evidence for a prejunctional effect on neuromuscular function. Nature. 1974;247:49–50.PubMedCrossRefGoogle Scholar
  9. 9.
    Perlstein MA, Attala R. Neurological sequela of plumbism in ­children. Clin Pediatr. 1966;5:292–8.CrossRefGoogle Scholar
  10. 10.
    Berger AR, Schaumburg HH. Effects of occupational and environmental agents on the nervous system. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. Boston: Butterworth-Heinemann; 1996. p. 1389–401.Google Scholar
  11. 11.
    Dyer J, Garrick DP, Inglis A, Pye IF. Plumboporphyria (ALAD deficiency) in a lead worker: a scenario for potential diagnostic confusion. Br J Ind Med. 1993;50:1119–21.PubMedGoogle Scholar
  12. 12.
    Machle WF. Tetra-ethyl lead intoxication and poisoning by related compounds of lead. JAMA. 1935;105:578–85.CrossRefGoogle Scholar
  13. 13.
    Chancellor AM, Slattery JM, Fraser H, Warlow CP. Risk factors for motor neuron disease: a case–control study based on patients from the Scottish motor disease registry. J Neurol Neurosurg Psychiatry. 1993;56:1200–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Rubens O, Logina I, Kravale I, Eglite M, Donaghy M. Peripheral neuropathy in chronic occupational inorganic lead exposure: a clinical and electrophysiologic study. J Neurol Neurosurg Psychiatry. 2001;71:200–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Karimooy HN, Mood MB, Hosseini M, Shadmanfar S. Effects of occupational lead exposure on renal and nervous system of workers of traditional tile factories in Mashhad (northeast of Iran). Toxicol Ind Health. 2010;26:633–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Markowitz ME, Rosen JF. Need for the lead mobilization test in children with lead poisoning. J Pediatr. 1991;119:305–10.PubMedCrossRefGoogle Scholar
  17. 17.
    Seppalainen AM, Tola S, Herberg S, Kock B. Subclinical neuropathy at “safe” levels of lead exposure. Arch Environ Health. 1975;30:180–3.PubMedCrossRefGoogle Scholar
  18. 18.
    Feldman RG. Arsenic. In: Occupational and environmental toxicology. Philadelphia: Lippincott-Raven Publishers; 1999. p. 69–91.Google Scholar
  19. 19.
    Kreiss K, Zack MW, Feldman RG, Landrigan PJ, Boyd MH, Cox DH. Neurologic evaluation of a population exposed to arsenic in Alaskan well water. Arch Environ Health. 1983;38:116–21.PubMedCrossRefGoogle Scholar
  20. 20.
    Rahman MM, Sengupta MK, Ahamed S, et al. Arsenic contamination of groundwater and its health impact on residents in a village in West Bengal, India. Bull World Health Organ. 2005;83(1):49–57.PubMedGoogle Scholar
  21. 21.
    Peters HA, Croft WA, Woolson EA, Darcey B, Olson M. Hematologic, dermal and neuropsychologic disease from burning and powersawing chromium copper arsenic (CCA) treated wood. Acta Pharmacol Toxicol. 1987;59 suppl 7suppl 7:39–43.Google Scholar
  22. 22.
    Klassen C. Heavy metals and heavy metal antagonists. In: Goodman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman’s: the pharmacological basis of therapeutics. Elmsford: Pergamon Press; 1990. p. 1602–5.Google Scholar
  23. 23.
    O’Shaughnessy E, Kraft GK. Arsenic poisoning: long-term follow-up of a nonfatal case. Arch Phys Med Rehabil. 1976;57:403–6.PubMedGoogle Scholar
  24. 24.
    Oh SJ. Electrophysiological profile in arsenic. Neuropathy. 1993;54:1103–5.Google Scholar
  25. 25.
    Donofrio PD, Wilbourn AM, Albers JW, et al. Acute arsenic intoxication presenting as Guillain Barré-like syndrome. Muscle Nerve. 1987;10:114–20.PubMedCrossRefGoogle Scholar
  26. 26.
    Moyer TP. Testing for arsenic. Mayo Clin Proc. 1993;68:1210–1.PubMedCrossRefGoogle Scholar
  27. 27.
    Heyman A, Pfeiffer JB, Taylor HM. Peripheral neuropathy caused by arsenical intoxication: a study of 41 cases with observation on the effects of BAL (2,3-dimercapto-propanol). N Engl J Med. 1956;254:401–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Fincher RME, Koerker RM. Long term survival in acute arsenic encephalopathy: follow-up using newer measures of electrophysiological parameters. Am J Med. 1987;82:549–52.PubMedCrossRefGoogle Scholar
  29. 29.
    Feldman RG. Thallium. In: Occupational and environmental toxicology. Philadelphia: Lippincott-Raven Publishers; 1999. p. 115–28.Google Scholar
  30. 30.
    Moeschlin S. Thallium poisoning. Clin Toxicol. 1980;17:133–46.PubMedCrossRefGoogle Scholar
  31. 31.
    Davis LE, Standefer JC, Kornfeld M, Abercrombie DM, Butler C. Acute thallium poisoning: toxicological and morphological studies of the nervous system. Ann Neurol. 1981;10:38–44.PubMedCrossRefGoogle Scholar
  32. 32.
    Douglas KT, Bunni MA, Baindur SR. Minireview: thallium in ­biochemistry. Int J Biochem. 1990;22:429–38.PubMedCrossRefGoogle Scholar
  33. 33.
    Nordentoft T, Anderson EB, Morgensen PH. Initial sensorimotor and delayed autonomic neuropathy in acute thallium poisoning. Neurotoxicology. 1998;19:421–6.PubMedGoogle Scholar
  34. 34.
    Moore D, House I, Dixon A. Thallium poisoning: diagnosis may be elusive but alopecia is the clue. Br Med J. 1993;306(6891):1527–9.CrossRefGoogle Scholar
  35. 35.
    Dumitru D, Kalantri A. Electrophysiological investigation of thallium poisoning. Muscle Nerve. 1990;13:433–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Lehmann PA, Favari L. Parameters for the adsorption of thallium ions by activated charcoal and Prussian blue. J Toxicol Clin Toxicol. 1984;22:331–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Feldman RG. Mercury. In: Occupational and environmental toxicology. Philadelphia: Lippincott-Raven Publishers; 1999. p. 92–114.Google Scholar
  38. 38.
    Bakir F, Damluji SF, Amin-Zaki L, et al. Methylmercury poisoning in Iraq. Science. 1973;181:230–41.PubMedCrossRefGoogle Scholar
  39. 39.
    Berglund A. Estimation by 24 hour study of the daily dose of ­intra-oral mercury vapor inhaled from dental amalgam. J Dent Res. 1990;69:1646–51.PubMedCrossRefGoogle Scholar
  40. 40.
    Barregard L, Ellingsen D, Alexander J, et al. People with high ­mercury uptake from their own dental amalgam fillings. Occup Environ Med. 1995;52:124–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Pleva J. Dental mercury: a public health hazard. Rev Environ Health. 1994;10:1–27.PubMedCrossRefGoogle Scholar
  42. 42.
    Clausen J. Mercury and multiple sclerosis. Acta Neurol Scand. 1993;87:461–4.PubMedCrossRefGoogle Scholar
  43. 43.
    Brune D, Evje DM. Man’s mercury loading from a dental amalgam. Sci Total Environ. 1985;44:51–63.PubMedCrossRefGoogle Scholar
  44. 44.
    Bluhm RE, Bobbitt RG, Welch LW, et al. Elemental mercury vapor toxicity, treatment and prognosis after acute intensive exposure in chloralkali workers. Part I. History, neuropsychological findings and chelator effects. Hum Exp Toxicol. 1992;11:201–10.PubMedCrossRefGoogle Scholar
  45. 45.
    Adams CR, Ziegler DK, Lin JT. Mercury intoxication simulating amyotrophic lateral sclerosis. JAMA. 1983;250:642–3.PubMedCrossRefGoogle Scholar
  46. 46.
    Albers JW, Kallenbach LR, Fine LJ, Mercury Studies Group, et al. Neurological abnormalities associated with remote occupational elemental mercury exposure. Ann Neurol. 1988;24:651–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Singer R, Valciukas JA, Rosenman KD. Peripheral nerve toxicity in workers exposed to inorganic mercury compounds. Arch Environ Health. 1987;42:181–4.PubMedGoogle Scholar
  48. 48.
    Campbell D, Gonzales M, Sullivan Jr JB. Mercury. In: Sullivan Jr JB, Krieger GR, editors. Hazardous materials toxicology: clinical principles of environmental health. Baltimore: Williams and Wilkins; 1992. p. 824–34.Google Scholar
  49. 49.
    Kane FJ. Carbon disulfide intoxication from overdose of disulfiram. Am J Psychiatry. 1970;127:690–4.PubMedGoogle Scholar
  50. 50.
    Seppalainen AM, Haltia M. Carbon disulfide. In: Spencer PS, Schaumburg HH, editors. Experimental and clinical neurotoxicology. Baltimore: William and Wilkins; 1980. p. 356–73.Google Scholar
  51. 51.
    Vigliani EC. Carbon disulfide poisoning in viscose rayon factories. Br J Ind Med. 1954;11:235–44.PubMedGoogle Scholar
  52. 52.
    Feldman RG. Occupational and environmental toxicology. Philadelphia: Lippincott-Raven Publishers; 1999. p. 400–20.Google Scholar
  53. 53.
    Gordy ST, Trumper M. Carbon disulfide poisoning with a report of six cases. JAMA. 1938;110:1543–9.CrossRefGoogle Scholar
  54. 54.
    Chu C-C, Huang C-C, Chen R-S, Shih T-S. Polyneuropathy induced by carbon disulfide in viscose rayon workers. Occup Environ Med. 1995;52:404–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Seppalainen AM, Tolonen M. Neurotoxicity of long-term exposure to carbon disulfide in the viscose rayon industry. A neurophysiologic study. Work Environ Health. 1974;11:145–53.Google Scholar
  56. 56.
    Feldman RG. Acrylamide. In: Occupational and environmental toxicology. Philadelphia: Lippincott-Raven Publishers; 1999. p. 337–58.Google Scholar
  57. 57.
    Gold BG, Griffin JW, Price DL. Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration. J Neurosci. 1985;5:1755–68.PubMedGoogle Scholar
  58. 58.
    Miller MS, Spencer PS. Single doses of acrylamide reduce retrograde transport velocity. J Neurochem. 1984;43:1401–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Schaumburg HH, Arezzo JC, Spencer PS. Delayed onset of axonal neuropathy in primates after prolonged low-level administration of a neurotoxin. Ann Neurol. 1989;26:576–9.PubMedCrossRefGoogle Scholar
  60. 60.
    Spencer PS, Schaumburg HH. Ultrastructural studies of the dying back process. III. The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol. 1977;36:276–99.PubMedCrossRefGoogle Scholar
  61. 61.
    Abou-Donia MB, Ibrahim SM, Corcoran JJ, et al. Neurotoxicity of glycidamide, an acrylamide metabolite. J Toxicol Environ Health. 1993;39:447–64.PubMedCrossRefGoogle Scholar
  62. 62.
    Spencer PS, Schaumburg HH. Central-peripheral distal axonopathy- the pathogenesis of dying back polyneuropathies. In: Zimmerman H, editor. Progress in neuropathology, vol. 3. New York: Grune and Stratton; 1976. p. 253–95.Google Scholar
  63. 63.
    Schaumburg HH, Wisniewski HM, Spencer PS. Ultrastructural studies of the dying-back process. 1. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol. 1974;33:260–84.PubMedCrossRefGoogle Scholar
  64. 64.
    Fullerton PM. Electrophysiologic and histologic observations on the peripheral nerves in acrylamide poisoning. J Neurol Neurosurg Psychiatry. 1969;32:186–92.PubMedCrossRefGoogle Scholar
  65. 65.
    Coye MJ. The health effects of agricultural production. I. The health of agricultural workers. J Public Health Policy. 1985;6:349–70.PubMedCrossRefGoogle Scholar
  66. 66.
    Metcalf DR, Holmes JH. EEG, psychological and neurological alterations in humans with organophosphorous exposure. Ann N Y Acad Sci. 1969;160:357–65.PubMedCrossRefGoogle Scholar
  67. 67.
    Wadia RS, Sadagtopan C, Amin RB, Sardesai HV. Neurological manifestations of organophosphorous insecticide poisoning. J Neurol Neurosurg Psychiatry. 1974;37:841–7.PubMedCrossRefGoogle Scholar
  68. 68.
    DeBleecker J. The intermediate syndrome in organophosphate poisoning: an overview of experimental and clinical observations. Clin Toxicol. 1995;33:683–6.CrossRefGoogle Scholar
  69. 69.
    Wadia RS, Chitra S, Amin RB, Kiwalkar RS, Sardesai HV. Electrophysiologic studies in acute organophosphate poisoning. J Neurol Neurosurg Psychiatry. 1987;50:1442–8.PubMedCrossRefGoogle Scholar
  70. 70.
    Besser R, Gutman L, Dillmann U, Weilemann LS, Hopf HC. End-plate dysfunction in acute organophosphate intoxication. Neurology. 1989;39:561–7.PubMedCrossRefGoogle Scholar
  71. 71.
    Misra UK, Nag D, Khan WA, Ray PK. A study of nerve conduction velocity, late responses and neuromuscular synapse function in organophosphate workers in India. Arch Toxicol. 1988;61:496–500.PubMedCrossRefGoogle Scholar
  72. 72.
    Benson B, Tolo D. Is the intermediate syndrome in organophosphate poisoning the result of inadequate oxime therapy? Clin Toxicol. 1992;30:347–9.CrossRefGoogle Scholar
  73. 73.
    O’Donoghue JL, Krasavage WJ. Hexacarbon neuropathy: a gamma-diketone neuropathy? J Neuropathol Exp Neurol. 1979;38:333 (abstract).CrossRefGoogle Scholar
  74. 74.
    Cianchetti C, Abbritti G, Perticoni G, Siracusa A, Curradi F. Toxic polyneuropathy of shoe industry workers: a study of 122 cases. J Neurol Neurosurg Psychiatry. 1982;39:1151–61.CrossRefGoogle Scholar
  75. 75.
    Herskowitz A, Ishii N, Schaumburg H. N-hexane neuropathy: a syndrome occurring as a result of industrial exposure. N Eng J Med. 1971;285:82–5.CrossRefGoogle Scholar
  76. 76.
    Iida M, Yamamura Y, Sobue I. Electromyographic findings and conduction velocity on n-hexane polyneuropathy. Electromyography. 1969;9:247–61.PubMedGoogle Scholar
  77. 77.
    Mendell JR, Saida K, Ganansia MG, et al. Toxic polyneuropathy produced by methyl n-butyl ketone. Science. 1974;185:787–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Gonzalez EG, Downey JA. Polyneuropathy in a glue sniffer. Arch Phys Med Rehabil. 1972;53:333–7.PubMedGoogle Scholar
  79. 79.
    Davenport JG, Farrell DF, Sumi SM. “Giant axonal neuropathy” caused by industrial chemicals: neurofilamentous axonal masses in man. Neurology. 1976;26:919–23.PubMedCrossRefGoogle Scholar
  80. 80.
    Asbury AK, Gale MK, Cox SC, Baringer JR, Berg BO. Giant axonal neuropathy: a unique case with segmental neurofilamentous masses. Acta Neuropathol. 1972;20:237–47.PubMedCrossRefGoogle Scholar
  81. 81.
    Korobkin R, Asbury AK, Sumner AJ, Nielsen SL. Glue sniffing neuropathy. Arch Neurol. 1975;32:158–62.PubMedCrossRefGoogle Scholar
  82. 82.
    Feldman RG. Occupational and environmental toxicology. Philadelphia: Lippincott-Raven Publishers; 1999. p. 421–41.Google Scholar
  83. 83.
    Aiello I, Rosati G, Serra G, Manca M. Subclinical neuropathic ­disorders and precautionary measures in the shoe industry. Acta Neurol. 1980;35:285–91.Google Scholar
  84. 84.
    Cardona A, Marhuenda D, Marti J, Brugnone F, Roel J, Perbellini L. Biological monitoring of occupational exposure to n-hexane by measurement of urinary 2,5-hexanedione. Int Arch Occup Environ Health. 1993;65:71–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of NeurologyUniversity of FloridaJacksonvilleUSA
  2. 2.Department of NeurologyUniversity of Florida College of MedicineJacksonvilleUSA

Personalised recommendations